Limited real-world data are available regarding the comparison about safety and efficacy of DOACs prescription in very elderly patients (≥85 years) with non-valvular atrial fibrillation (NVAF). Concern about the risk of bleeding with anticoagulation in very older patients still represents an important challenge for clinicians.
Safety and efficacy of Direct Oral Anticoagulants (DOACs) in very elderly patients (≥ 85 years old) with non-valvular atrial fibrillation. The Experience of an Italian tertiary care center / Rubino, Claudia; Blunda, Fabiana; Bodega, Francesca; Melillo, Francesco; Russi, Anita; Mattiello, Paolo; Salerno, Anna; Cera, Michela; Margonato, Davide; Mazzone, Patrizio; Della Bella, Paolo; Castiglioni, Alessandro; Alfieri, Ottavio; DE Bonis, Michele; Montorfano, Matteo; Filippi, Massimo; Tresoldi, Moreno; Cappelletti, Alberto; Zangrillo, Alberto; Margonato, Alberto; Godino, Cosmo. - In: MINERVA MEDICA. - ISSN 1827-1669. - 114:2(2023), pp. 137-147. [10.23736/S0026-4806.21.07432-2]
Safety and efficacy of Direct Oral Anticoagulants (DOACs) in very elderly patients (≥ 85 years old) with non-valvular atrial fibrillation. The Experience of an Italian tertiary care center
Castiglioni, Alessandro;Alfieri, Ottavio;DE Bonis, Michele;Montorfano, Matteo;Filippi, Massimo;Zangrillo, Alberto;Margonato, AlbertoPenultimo
;
2023-01-01
Abstract
Limited real-world data are available regarding the comparison about safety and efficacy of DOACs prescription in very elderly patients (≥85 years) with non-valvular atrial fibrillation (NVAF). Concern about the risk of bleeding with anticoagulation in very older patients still represents an important challenge for clinicians.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
